NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/18/2025
Back to search
Official data from USPTO
XIRKELSI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
02/18/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
09/27/2023
Registration date
02/18/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2025
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Leeds, GB
Examiner
SIEGEL, PAIGE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Rosemont Pharmaceuticals Limited
Representatives
Mark C. Reichel REICHEL STOHRY DEAN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations for patients suffering from dysphagia and conditions requiring medication in liquid form for the treatment of viral, bacterial, parasitic and fungal diseases and infections; oral liquid medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; drugs for medical purposes in the nature of medicines for the treatment of viral, bacterial, parasitic and fungal diseases and infections; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of a wide range of pharmaceuticals; substances, drugs, medicines and medical preparations, namely, drug delivery agents consisting of compounds in the form of oral liquid medicines, oral suspensions, dispersible and soluble tablets, and powders to be consumed in liquid form, that facilitate the delivery of anti-infective agents, antineoplastic agents, cardiovascular agents, central nervous system agents, coagulation modifiers, gastrointestinal agents, genitourinary tract agents, psychotherapeutic agents and metabolic agents
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2024
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2024
ALIE
ASSIGNED TO LIE
10/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/22/2024
GNRT
NON-FINAL ACTION E-MAILED
05/22/2024
CNRT
NON-FINAL ACTION WRITTEN
05/22/2024
DOCK
ASSIGNED TO EXAMINER
05/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2023
NWAP
NEW APPLICATION ENTERED
09/30/2023
Continuous trademark protection
Get notified about every new filing that threatens XIRKELSI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.